You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mRNA, Prevention

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)

Not yet recruiting
  • SARS-CoV-2
  • LVRNA009
  • 0.9%NaCl
  • (no location specified)
Jan 11, 2023

Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

Not yet recruiting
  • Influenza
  • +3 more
  • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
  • +2 more
  • Phoenix, Arizona
  • +7 more
Aug 30, 2023

HIV Trial in United States (BG505 MD39.3 mRNA, BG505 MD39.3 gp151 mRNA, BG505 MD39.3 gp151 CD4KO mRNA)

Suspended
  • HIV Infections
  • BG505 MD39.3 mRNA
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 1, 2023

SARS-CoV-2 Trial in Changsha, Xiangtan (SARS-CoV-2 (LVRNA009) 50µg group, SARS-CoV-2 (LVRNA009) 100µg group, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 (LVRNA009) 50μg group
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Jul 19, 2022

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood

Not yet recruiting
  • Fever After Vaccination
  • +2 more
  • Pfizer-BioNTech COVID-19 Vaccine
  • Routine Childhood Vaccinations
  • Oakland, California
  • +4 more
Sep 8, 2023

COVID-19 Trial in Beijing, Langfang, Changsha (COVID-19 mRNA vaccine, Placebo)

Recruiting
  • COVID-19
  • COVID-19 mRNA vaccine
  • Placebo
  • Beijing, Beijing, China
  • +2 more
Jul 8, 2022

COVID-19 Trial in Beijing, Langfang, Changsha (COVID-19 mRNA vaccine, Placebo)

Recruiting
  • COVID-19
  • COVID-19 mRNA vaccine
  • Placebo
  • Beijing, Beijing, China
  • +2 more
Jul 4, 2022

Pain, Quality of Life, Injection Site Reaction Trial in Baltimore, Durham, Cincinnati (mRNA COVID-19, IIV4, Placebo)

Suspended
  • Pain
  • +3 more
  • mRNA COVID-19
  • +2 more
  • Baltimore, Maryland
  • +2 more
Jun 21, 2022

SARS-CoV-2 Infection Trial in Shijia Zhuang (SYS6006)

Recruiting
  • SARS-CoV-2 Infection
  • SYS6006
  • Shijia Zhuang, Hebei, China
    Hebei Provincial Center For Disease Control and Prevention
Jul 4, 2022

SARS-CoV-2 Trial in Jiangsu (BNT162b2, Placebo)

Completed
  • SARS-CoV-2
  • BNT162b2
  • Placebo
  • Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 9, 2022

Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345)

Not yet recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Glendale, Arizona
  • +47 more
Sep 27, 2023

Prevention of Chikungunya Virus Infection Trial in Austin (mRNA-1944, Placebo)

Completed
  • Prevention of Chikungunya Virus Infection
  • mRNA-1944
  • Placebo
  • Austin, Texas
    PPD Phase 1 Clinical Research Unit
Jul 5, 2021

COVID-19, Vaccine Immune Response, Vaccine Adverse Reaction Trial in Incheon, Seoul, Suwon (mRNA-1273 COVID-19 vaccine)

Recruiting
  • COVID-19
  • +2 more
  • mRNA-1273 COVID-19 vaccine
  • Incheon, Korea, Republic of
  • +4 more
Feb 25, 2022

Covid19 Vaccine Trial in Toronto (PTX-COVID19-B, Placebo)

Completed
  • Covid19 Vaccine
  • PTX-COVID19-B
  • Placebo
  • Toronto, Ontario, Canada
    Manna Research
Apr 22, 2022

COVID-19 Vaccination, Inflammation, Vaccine Immune Response Trial in Suwon, Seoul (either BNT162b2 or ChAdOx1 vaccine)

Recruiting
  • COVID-19 Vaccination
  • +3 more
  • either BNT162b2 or ChAdOx1 vaccine
  • Suwon, Gyeonggi-do, Korea, Republic of
  • +2 more
Apr 6, 2022

Covid19 Vaccine Trial in Canada, South Africa (PTX-COVID19-B, Pfizer-BioNTech COVID-19 vaccine, Placebo)

Active, not recruiting
  • Covid19 Vaccine
  • PTX-COVID19-B
  • +2 more
  • Mississauga, Ontario, Canada
  • +9 more
Apr 22, 2022

Prevention of COVID19 Trial (mRNA-1273)

Not yet recruiting
  • Prevention of COVID19
  • mRNA-1273
  • (no location specified)
Feb 6, 2021

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

Study of Lung Health Among Workers Exposed to Diesel Exhaust

Completed
  • Inflammation Biomarkers
  • +2 more
    • Bejing, China
      Chinese Center for Disease Control & Prevention
    Nov 12, 2020

    Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)

    Recruiting
    • Seasonal Influenza
    • mRNA-1011.1
    • +5 more
    • Lakewood, California
    • +21 more
    Apr 12, 2023

    Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)

    Not yet recruiting
    • Norovirus Acute Gastroenteritis
    • mRNA-1403
    • +2 more
    • Long Beach, California
    • +14 more
    Aug 7, 2023